Goldstone Financial Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$677K Sell
7,382
-350
-5% -$30.6K 0.06% 161
2026
Q1
$659K Sell
7,732
-1,545
-17% -$138K 0.07% 148
2025
Q4
$733K Buy
9,277
+793
+9% +$62.2K 0.08% 138
2025
Q3
$678K Buy
8,484
+1,319
+18% +$113K 0.08% 144
2025
Q2
$665K Buy
7,165
+938
+15% +$85.6K 0.09% 133
2025
Q1
$584K Buy
6,227
+17
+0.3% +$1.52K 0.09% 124
2024
Q4
$565K Buy
6,210
+781
+14% +$74.5K 0.09% 116
2024
Q3
$564K Buy
5,429
+605
+13% +$61.7K 0.1% 109
2024
Q2
$468K Buy
4,824
+355
+8% +$32.7K 0.09% 114
2024
Q1
$402K Buy
4,469
+140
+3% +$11.9K 0.09% 113
2023
Q4
$345K Buy
4,329
+88
+2% +$6.62K 0.09% 114
2023
Q3
$302K Sell
4,241
-248
-6% -$18.5K 0.09% 114
2023
Q2
$346K Buy
4,489
+247
+6% +$19.1K 0.1% 111
2023
Q1
$319K Buy
+4,242
New +$315K 0.11% 109

Other funds holding CL

Goldstone Financial Group's CL Position: Q2 2026 in Review

Goldstone Financial Group reduced its Colgate-Palmolive (CL) stake by 4.5% in Q2 2026, selling an estimated $30.6K and leaving 7,382 shares worth $677K. The position accounts for 0.06% of the portfolio, ranked #161.

Goldstone Financial Group first reported a position in CL in Q1 2023 and has held it in 14 quarters since. The position peaked at $733K in Q4 2025. 2,025 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Goldstone Financial Group held 7,382 shares of Colgate-Palmolive worth $677K as of Q2 2026.
  • Goldstone Financial Group sold 350 Colgate-Palmolive shares in Q2 2026, an estimated $30.6K.
  • Colgate-Palmolive made up 0.06% of Goldstone Financial Group's portfolio in Q2 2026, its #161 holding.
  • Goldstone Financial Group first reported a position in Colgate-Palmolive in Q1 2023 and has held it in 14 quarters since.
  • Goldstone Financial Group's Colgate-Palmolive position peaked at $733K in Q4 2025.
  • 2,025 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Goldstone Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.